ADMA Biologics ADMA Income taxes at U.S. statutory rate of 21%
Income taxes at U.S. statutory rate of 21% at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's income taxes at u.s. statutory rate of 21%.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's income taxes at U.S. statutory rate of 21%?
- ADMA Biologics (ADMA) reported income taxes at U.S. statutory rate of 21% of 20.7% in Q1 2026.
- How has ADMA Biologics's income taxes at U.S. statutory rate of 21% changed year-over-year?
- ADMA Biologics's income taxes at U.S. statutory rate of 21% increased by 5.6% year-over-year, from 19.6% to 20.7%.
- What does income taxes at U.S. statutory rate of 21% mean?
- The percentage impact on the effective tax rate resulting from the application of the federal statutory tax rate to pre-tax income. This metric is used in tax rate reconciliations to explain the difference between the statutory rate and the company's actual effective tax rate. It provides transparency into the primary drivers of the company's tax profile.